University of East Anglia Researchers Develop Non-Invasive Prostate Cancer Urine Test

The researchers believe their test ‘could reduce the number of unnecessary prostate cancer biopsies by 32%,’ UEA reported New diagnostic technologies may make it possible for men to provide a urine sample that can allow a clinical laboratory to not only accurately diagnose prostate cancer but also help determine whether it is an aggressive form of prostate cancer. Researchers in the United Kingdom (UK) recently described just such a test in an online, peer-reviewed journal. Development of a...

Polygenic Scores Show Potential to Predict Humans’ Susceptibility to a Range of Chronic Diseases; New Clinical Laboratory Genetic Tests Could Result from Latest Research

Access to vast banks of genomic data is powering a new wave of assessments and predictions that could offer a glimpse at how genetic variation might impact everything from Alzheimer’s Disease risk to IQ scores Anatomic pathology groups and clinical laboratories have become accustomed to performing genetic tests for diagnosing specific chronic diseases in humans. Thanks to significantly lower costs over just a few years ago, whole-genome sequencing and genetic DNA testing are on the path to...

New Super-Sensitive Clinical Lab Test Technology Combines ELISA and Nanotechnology for Simpler, Cheaper and Earlier Detection of Disease

Pathologists and clinical laboratory managers can expect to see new technology translated to a wide variety of diagnostic tests Researchers claim a new diagnostic technology for detecting the HIV virus is 10 times more sensitive than traditional techniques. More remarkable is the fact that this new technology enables analyte detection at very low concentrations with the naked eye! Pathologists and clinical laboratory managers won’t see this technology enter clinical use for some time. That is...

UPMC Pathologists and Researchers Develop Technology That Predicts Prostate Cancer Relapse

New lab test market could open up if research findings lead to a useful clinical laboratory test that predicts prostate cancer recurrence Over the past decade, clinical laboratory tests that can predict the occurrence or recurrence of breast cancer have opened up a profitable market for the companies that developed these technologies. Now, new research may become the basis of a useful medical laboratory test that could be predictive of prostate cancer relapse. Of course, pathologists know that...
;